Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The relationship between bone lead and hemoglobin

H Hu1, H Watanabe, M Payton

  • 1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.

JAMA
|November 16, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

On the asymptotic validity of confidence sets for linear functionals of solutions to integral equations.

Biometrika·2025
Same author

Multiple robustness in factorized likelihood models.

Biometrika·2018
Same author

P2X1-initiated p38 signalling enhances thromboxane A2-induced platelet secretion and aggregation.

Thrombosis and haemostasis·2014
Same author

Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2014
Same author

320 Gb/s Nyquist OTDM received by polarization-insensitive time-domain OFT.

Optics express·2014
Same author

Excessive activation of the alternative complement pathway in autosomal dominant polycystic kidney disease.

Journal of internal medicine·2014
Same journal

WHO Issues Guidelines for Treating Ebola and Marburg Viruses.

JAMA·2026
Same journal

FDA Approves Additional Naloxone Nasal Spray for Opioid Overdose.

JAMA·2026
Same journal

HIV May Hide in More Cells Than Previously Thought-Here's What That Could Mean for a Cure.

JAMA·2026
Same journal

US Dietary Supplement Use Increasing, Especially in Older Adults.

JAMA·2026
Same journal

Heat Stress From Climate Change Surges Globally.

JAMA·2026
Same journal

Strength Training Linked With Lower Cardiovascular Disease Risk in Women.

JAMA·2026
See all related articles

Bone lead levels, particularly in the patella, are linked to reduced hemoglobin and hematocrit, indicating chronic toxicity. This finding suggests bone lead is a more sensitive marker than blood lead for long-term health effects.

Area of Science:

  • Environmental Health
  • Toxicology
  • Occupational Medicine

Background:

  • Lead exposure is a significant public health concern, with chronic toxicity potentially affecting various physiological systems.
  • Traditional monitoring relies on blood lead levels, but their sensitivity for detecting long-term, subclinical effects is debated.
  • Bone lead, a reservoir for lead in the body, may offer insights into cumulative exposure and toxicity.

Purpose of the Study:

  • To investigate whether bone lead concentration is a more sensitive biological marker for chronic lead toxicity compared to blood lead levels.
  • To assess the association between bone lead levels and hematological parameters in construction workers.

Main Methods:

  • A survey design was employed, including participants from a construction trade union.

Related Experiment Videos

  • In vivo measurements of bone lead (tibia and patella) using X-ray fluorescence and blood lead levels were conducted.
  • Hematocrit, hemoglobin, blood pressure, and serum creatinine were measured, along with self-reported medical history, smoking, and alcohol use.
  • Main Results:

    • Patella bone lead levels showed a significant correlation with decreased hemoglobin and hematocrit, even after adjusting for confounders.
    • Blood lead levels were low and not associated with hematological changes.
    • Increased patella bone lead was associated with a notable decrease in hemoglobin and hematocrit, suggesting a subclinical impact.

    Conclusions:

    • Patella bone lead levels are associated with reduced hematocrit and hemoglobin, indicating potential subclinical toxicity.
    • Bone lead, specifically in the patella, may serve as a more sensitive biomarker for chronic lead toxicity than blood lead.
    • This study provides epidemiological evidence for bone lead's role in ongoing chronic toxicity, impacting hematopoiesis.